AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Nano Research Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article

Advances of nanoparticles in transmucosal drug delivery

Li Zhang1,7,§, Changwei Yang2,§, Yingxiang Song1,7,§, Tao Sheng2, Junyan Li2,3, Jicheng Yu2,3,4,5,6( ), Xiaohong Wu1,7( ), Xiao Ye1,7( )
Geriatric Medicine Center, Department of Endocrinology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou 310014, China
Key Laboratory of Advanced Drug Delivery Systems of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
Jinhua Institute of Zhejiang University, Jinhua 321299, China
Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou 311121, China
Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China
National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China
Key Laboratory for Diagnosis and Treatment of Endocrine Gland Diseases of Zhejiang Province, Hangzhou 310014, China

§ Li Zhang, Changwei Yang, and Yingxiang Song contributed equally to this work.

Show Author Information

Graphical Abstract

This work elucidated the successful synthesis of a self-supported electrode for hydrogen evolution reaction (HER) in water electrolysis. The WS2/N-rGO/CC (nitrogen-doped reduced graphene oxide (N-rGO) nanoflakes and WS2 hierarchical nanoflower grown directly on carbon cloth (CC) substrate) electrode achieved excellent stability and durability at a high current density, meanwhile exhibiting lower overpotential and Tafel slope compared to Pt-based catalysts, making it a promising alternative for practical applications in energy-saving hydrogen production.

Abstract

Transmucosal drug administration represents a potential strategy for enhancing treatment efficacy and reducing side effects by avoiding the first-pass effect into the systemic circulation and delivering therapeutics directly to the target disease site. However, many challenges still remain in its clinical application, including low drug availability and limited retention time in the mucosa. The burgeoning advancement of nanotechnologies offers great potential to overcome the above limitations, leveraging their distinct advantages of high drug-loading capacity and strong permeability. In this review, the latest developments of nanoparticles (NPs) in transmucosal drug delivery as well as their clinical applications are discussed.

Keywords

nanoparticles (NPs)transmucosal drug deliverymucosal barriersbiomaterials

References

[1]

Patel, V. F.; Liu, F.; Brown, M. B. Advances in oral transmucosal drug delivery. J. Control. Release 2011, 153, 106–116.
Crossref Google Scholar
[2]

Purohit, T. J.; Hanning, S. M.; Wu, Z. M. Advances in rectal drug delivery systems. Pharm. Dev. Technol. 2018, 23, 942–952.
Crossref Google Scholar
[3]

Kompella, U. B.; Kadam, R. S.; Lee, V. H. Recent advances in ophthalmic drug delivery. Ther. Deliv. 2010, 1, 435–456.
Crossref Google Scholar
[4]

Chauhan, A.; Fitzhenry, L.; Serro, A. P. Recent advances in ophthalmic drug delivery. Pharmaceutics 2022, 14, 2075.
Crossref Google Scholar
[5]

Ugwoke, M. I.; Agu, R. U.; Verbeke, N.; Kinget, R. Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives. Adv. Drug Deliv. Rev. 2005, 57, 1640–1665.
Crossref Google Scholar
[6]

Abhang, P.; Momin, M.; Inamdar, M.; Kar, S. Transmucosal drug delivery—An overview. Drug Delivery Lett. 2014, 4, 26–37.
Crossref Google Scholar
[7]

Talkar, S.; Dhoble, S.; Majumdar, A.; Patravale, V. Transmucosal nanoparticles: Toxicological overview. Adv. Exp. Med. Biol. 2018, 1048, 37–57.
Google Scholar
[8]

Jain, S.; Khomane, K.; Jain, A. K.; Dani, P. Nanocarriers for transmucosal vaccine delivery. Curr. Nanosci. 2011, 7, 160–177.
Crossref Google Scholar
[9]

Leal, J.; Smyth, H. D. C.; Ghosh, D. Physicochemical properties of mucus and their impact on transmucosal drug delivery. Int. J. Pharmaceut. 2017, 532, 555–572.
Crossref Google Scholar
[10]

Lieleg, O.; Ribbeck, K. Biological hydrogels as selective diffusion barriers. Trends Cell Biol. 2011, 21, 543–551.
Crossref Google Scholar
[11]

Bansil, R.; Turner, B. S. Mucin structure, aggregation, physiological functions and biomedical applications. Curr. Opin. Colloid. Interface Sci. 2006, 11, 164–170.
Crossref Google Scholar
[12]

Cone, R. A. Barrier properties of mucus. Adv. Drug Deliv. Rev. 2009, 61, 75–85.
Crossref Google Scholar
[13]

Frenkel, E. S.; Ribbeck, K. Salivary mucins in host defense and disease prevention. J. Oral Microbiol. 2015, 7, 29759.
Crossref Google Scholar
[14]

Bayda, S.; Adeel, M.; Tuccinardi, T.; Cordani, M.; Rizzolio, F. The history of nanoscience and nanotechnology: From chemical-physical applications to nanomedicine. Molecules 2020, 25, 112.
Google Scholar
[15]

Shi, J. J.; Votruba, A. R.; Farokhzad, O. C.; Langer, R. Nanotechnology in drug delivery and tissue engineering: From discovery to applications. Nano Lett. 2010, 10, 3223–3230.
Crossref Google Scholar
[16]

Rizvi, S. A. A.; Saleh, A. M. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm. J. 2018, 26, 64–70.
Crossref Google Scholar
[17]

Patra, J. K.; Das, G.; Fraceto, L. F.; Campos, E. V. R.; del Pilar Rodriguez-Torres, M.; Acosta-Torres, L. S.; Diaz-Torres, L. A.; Grillo, R.; Swamy, M. K.; Sharma, S. et al. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnol. 2018, 16, 71.
Crossref Google Scholar
[18]

Prego, C.; García, M.; Torres, D.; Alonso, M. J. Transmucosal macromolecular drug delivery. J. Control. Release 2005, 101, 151–162.
Crossref Google Scholar
[19]

Farokhzad, O. C.; Langer, R. Impact of nanotechnology on drug delivery. ACS Nano 2009, 3, 16–20.
Crossref Google Scholar
[20]

Jani, P.; Halbert, G. W.; Langridge, J.; Florence, A. T. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol. 1989, 41, 809–812.
Google Scholar
[21]
Florence, A. T.; Hussain, N. Transcytosis of nanoparticle and dendrimer delivery systems: Evolving vistas. Adv. Drug Deliv. Rev. 2001 , 50 Suppl 1, S69–S89.
[22]

Takeuchi, H.; Yamamoto, H.; Kawashima, Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev. 2001, 47, 39–54.
Crossref Google Scholar
[23]

Barratt, G. Colloidal drug carriers: Achievements and perspectives. Cell. Mol. Life Sci. CMLS 2003, 60, 21–37.
Crossref Google Scholar
[24]

Janes, K. A.; Calvo, P.; Alonso, M. J. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev. 2001, 47, 83–97.
Crossref Google Scholar
[25]

LaVan, D. A.; McGuire, T.; Langer, R. Small-scale systems for in vivo drug delivery. Nat. Biotechnol. 2003, 21, 1184–1191.
Crossref Google Scholar
[26]

Macedo, A. S.; Castro, P. M.; Roque, L.; Thome, N. G.; Reis, C. P.; Pintado, M. E.; Fonte, P. Novel and revisited approaches in nanoparticle systems for buccal drug delivery. J. Control. Release 2020, 320, 125–141.
Crossref Google Scholar
[27]

Ways, T. M. M.; Ng, K. W.; Lau, W. M.; Khutoryanskiy, V. V. Silica nanoparticles in transmucosal drug delivery. Pharmaceutics 2020, 12, 751.
Crossref Google Scholar
[28]

Hua, S. S. Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration. Front. Pharmacol. 2019, 10, 1328.
Crossref Google Scholar
[29]

Laffleur, F.; Bauer, B. Progress in nasal drug delivery systems. Int. J. Pharm. 2021, 607, 120994.
Crossref Google Scholar
[30]

Muntimadugu, E.; Dhommati, R.; Jain, A.; Challa, V. G. S.; Shaheen, M.; Khan, W. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer’s disease. Eur. J. Pharm. Sci. 2016, 92, 224–234.
Crossref Google Scholar
[31]

Tang, S. N.; Wang, A. P.; Yan, X. J.; Chu, L. X.; Yang, X. C.; Song, Y. N.; Sun, K. X.; Yu, X.; Liu, R. X.; Wu, Z. M. et al. Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson’s disease. Drug Deliv. 2019, 26, 700–707.
Crossref Google Scholar
[32]

Fatouh, A. M.; Elshafeey, A. H.; Abdelbary, A. Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: Formulation, optimization and in vivo pharmacokinetics. Drug Des. Devel. Ther. 2017, 11, 1815–1825.
Crossref Google Scholar
[33]

Bari, N. K.; Fazil, M.; Hassan, Q.; Haider, R.; Gaba, B.; Narang, J. K.; Baboota, S.; Ali, J. Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder. Int. J. Biol. Macromol. 2015, 81, 49–59.
Crossref Google Scholar
[34]

Bhatt, R.; Singh, D.; Prakash, A.; Mishra, N. Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington’s disease. Drug Deliv. 2015, 22, 931–939.
Crossref Google Scholar
[35]

Jafarieh, O.; Md, S.; Ali, M.; Baboota, S.; Sahni, J. K.; Kumari, B.; Bhatnagar, A.; Ali, J. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting. Drug Dev. Ind. Pharm. 2015, 41, 1674–1681.
Crossref Google Scholar
[36]

Upadhyay, P.; Trivedi, J.; Pundarikakshudu, K.; Sheth, N. Direct and enhanced delivery of nanoliposomes of anti schizophrenic agent to the brain through nasal route. Saudi Pharm. J. 2017, 25, 346–358.
Crossref Google Scholar
[37]

Montegiove, N.; Calzoni, E.; Emiliani, C.; Cesaretti, A. Biopolymer nanoparticles for nose-to-brain drug delivery: A new promising approach for the treatment of neurological diseases. J. Funct. Biomater. 2022, 13, 125.
Crossref Google Scholar
[38]

Shringarpure, M.; Gharat, S.; Momin, M.; Omri, A. Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery. Expert Opin. Drug Deliv. 2021, 18, 169–185.
Crossref Google Scholar
[39]

Sonvico, F.; Clementino, A.; Buttini, F.; Colombo, G.; Pescina, S.; Guterres, S. S.; Pohlmann, A. R.; Nicoli, S. Surface-modified nanocarriers for nose-to-brain delivery: From bioadhesion to targeting. Pharmaceutics 2018, 10, 34.
Crossref Google Scholar
[40]

Erdő, F.; Bors, L. A.; Farkas, D.; Bajza, Á.; Gizurarson, S. Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Res. Bull. 2018, 143, 155–170.
Crossref Google Scholar
[41]

Albarki, M. A.; Donovan, M. D. Bigger or smaller. Size and loading effects on nanoparticle uptake efficiency in the nasal mucosa. AAPS PharmSciTech 2020, 21, 294.
Crossref Google Scholar
[42]

Naik, J. B.; Pardeshi, S. R.; Patil, R. P.; Patil, P. B.; Mujumdar, A. Mucoadhesive micro-/nano carriers in ophthalmic drug delivery: An overview. BioNanoScience 2020, 10, 564–582.
Crossref Google Scholar
[43]

Tian, B.; Bilsbury, E.; Doherty, S.; Teebagy, S.; Wood, E.; Su, W. Q.; Gao, G. P.; Lin, H. J. Ocular drug delivery: Advancements and innovations. Pharmaceutics 2022, 14, 1931.
Crossref Google Scholar
[44]

Urtti, A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv. Drug Deliv. Rev. 2006, 58, 1131–1135.
Crossref Google Scholar
[45]

Billowria, K.; Sandhu, N. K.; Singh, B. Topical advances in mucoadhesive ocular drug delivery system. Curr. Drug Deliv. 2023, 20, 1127–1140.
Crossref Google Scholar
[46]

Rossi, S.; Vigani, B.; Sandri, G.; Bonferoni, M. C.; Caramella, C. M.; Ferrari, F. Recent advances in the mucus-interacting approach for vaginal drug delivery: From mucoadhesive to mucus-penetrating nanoparticles. Expert Opin. Drug Deliv. 2019, 16, 777–781.
Crossref Google Scholar
[47]

Csaba, N.; Garcia-Fuentes, M.; Alonso, M. J. The performance of nanocarriers for transmucosal drug delivery. Expert Opin. Drug Deliv. 2006, 3, 463–478.
Crossref Google Scholar
[48]

Ying, L.; Wang, L. Y.; Guo, K. W.; Hou, Y. S.; Li, N.; Wang, S. Y.; Liu, X. F.; Zhao, Q. J.; Zhou, J.; Zhao, L. W. et al. Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects. Nat. Commun. 2021, 12, 7256.
Crossref Google Scholar
[49]

Sun, H. B.; Lin, W.; Tang, Y.; Tu, H. Q.; Chen, T.; Zhou, J.; Wang, D. Z.; Xu, Q. Q.; Niu, J. L.; Dong, W. L. Y. et al. Sustained remission of type 2 diabetes in rodents by centrally administered fibroblast growth factor 4. Cell Metab. 2023, 35, 1022–1037.e6.
Crossref Google Scholar
[50]

Dos Santos, G. A.; Ferreira-Nunes, R.; Dalmolin, L. F.; Dos Santos Ré, A. C.; Anjos, J. L. V.; Mendanha, S. A.; Aires, C. P.; Lopez, R. F. V.; Cunha-Filho, M.; Gelfuso, G. M. et al. Besifloxacin liposomes with positively charged additives for an improved topical ocular delivery. Sci. Rep. 2020, 10, 19285.
Crossref Google Scholar
[51]

Khalil, M.; Hashmi, U.; Riaz, R.; Abbas, S. R. Chitosan coated liposomes (CCL) containing triamcinolone acetonide for sustained delivery: A potential topical treatment for posterior segment diseases. Int. J. Biol. Macromol. 2020, 143, 483–491.
Crossref Google Scholar
[52]

Nguyen, T. T. L.; Maeng, H. J. Pharmacokinetics and pharmacodynamics of intranasal solid lipid nanoparticles and nanostructured lipid carriers for nose-to-brain delivery. Pharmaceutics 2022, 14, 572.
Crossref Google Scholar
[53]

Salah, E.; Abouelfetouh, M. M.; Pan, Y. H.; Chen, D. M.; Xie, S. Y. Solid lipid nanoparticles for enhanced oral absorption: A review. Colloids Surf. B. Biointerfaces 2020, 196, 111305.
Crossref Google Scholar
[54]

Uner, M.; Yener, G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int. J. Nanomedicine 2007, 2, 289–300.
Google Scholar
[55]

Rajpoot, K. Solid lipid nanoparticles: A promising nanomaterial in drug delivery. Curr. Pharm. Des. 2019, 25, 3943–3959.
Crossref Google Scholar
[56]

Akel, H.; Ismail, R.; Katona, G.; Sabir, F.; Ambrus, R.; Csóka, I. A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation. Int. J. Pharm. 2021, 604, 120724.
Crossref Google Scholar
[57]

Esim, O.; Savaser, A.; Ozkan, C. K.; Oztuna, A.; Goksel, B. A.; Ozler, M.; Tas, C.; Ozkan, Y. Nose to brain delivery of eletriptan hydrobromide nanoparticles: Preparation, in vitro/ in vivo evaluation and effect on trigeminal activation. J. Drug Deliv. Sci. Technol. 2020, 59, 101919.
Crossref Google Scholar
[58]

Ismail, R.; Bocsik, A.; Katona, G.; Gróf, I.; Deli, M. A.; Csóka, I. Encapsulation in polymeric nanoparticles enhances the enzymatic stability and the permeability of the GLP-1 analog, liraglutide, across a culture model of intestinal permeability. Pharmaceutics 2019, 11, 599.
Crossref Google Scholar
[59]

Trotta, V.; Pavan, B.; Ferraro, L.; Beggiato, S.; Traini, D.; Des Reis, L. G.; Scalia, S.; Dalpiaz, A. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles. Eur. J. Pharm. Biopharm. 2018, 127, 250–259.
Crossref Google Scholar
[60]

Bruinsmann, F. A.; Pigana, S.; Aguirre, T.; Souto, G. D.; Pereira, G. G.; Bianchera, A.; Fasiolo, L. T.; Colombo, G.; Marques, M.; Pohlmann, A. R. et al. Chitosan-coated nanoparticles: Effect of chitosan molecular weight on nasal transmucosal delivery. Pharmaceutics 2019, 11, 86.
Crossref Google Scholar
[61]

Jacob, S.; Nair, A. B.; Shah, J.; Gupta, S.; Boddu, S. H. S.; Sreeharsha, N.; Joseph, A.; Shinu, P.; Morsy, M. A. Lipid nanoparticles as a promising drug delivery carrier for topical ocular therapy—An overview on recent advances. Pharmaceutics 2022, 14, 533.
Crossref Google Scholar
[62]

Khames, A.; Khaleel, M. A.; El-Badawy, M. F.; El-Nezhawy, A. O. H. Natamycin solid lipid nanoparticles—Sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: Preparation and optimization. Int. J. Nanomed. 2019, 14, 2515–2531.
Crossref Google Scholar
[63]

Wadetwar, R. N.; Agrawal, A. R.; Kanojiya, P. S. In situ gel containing Bimatoprost solid lipid nanoparticles for ocular delivery: In- vitro and ex- vivo evaluation. J. Drug Deliv. Sci. Technol. 2020, 56, 101575.
Crossref Google Scholar
[64]
Tatke, A.; Dudhipala, N.; Janga, K. Y.; Balguri, S. P.; Avula, B.; Jablonski, M. M.; Majumdar, S. In situ gel of triamcinolone acetonide-loaded solid lipid nanoparticles for improved topical ocular delivery: Tear kinetics and ocular disposition studies. Nanomaterials (Basel) 2018 , 9, 33.
Crossref
[65]

Xing, R.; Mustapha, O.; Ali, T.; Rehman, M.; Zaidi, S. S.; Baseer, A.; Batool, S.; Mukhtiar, M.; Shafique, S.; Malik, M. et al. Development, characterization, and evaluation of SLN-loaded thermoresponsive hydrogel system of topotecan as biological macromolecule for colorectal delivery. BioMed Res. Int. 2021, 2021, 9968602.
Crossref Google Scholar
[66]

Din, F. U.; Jin, S. G.; Choi, H. G. Particle and gel characterization of irinotecan-loaded double-reverse thermosensitive hydrogel. Polymers (Basel) 2021, 13, 551.
Crossref Google Scholar
[67]

Kumar, M.; Tiwari, A.; Asdaq, S. M. B.; Nair, A. B.; Bhatt, S.; Shinu, P.; Al Mouslem, A. K.; Jacob, S.; Alamri, A. S.; Alsanie, W. F. et al. Itraconazole loaded nano-structured lipid carrier for topical ocular delivery: Optimization and evaluation. Saudi J. Biol. Sci. 2022, 29, 1–10.
Crossref Google Scholar
[68]

Lakhani, P.; Patil, A.; Taskar, P.; Ashour, E.; Majumdar, S. Curcumin-loaded nanostructured lipid carriers for ocular drug delivery: Design optimization and characterization. J. Drug Deliv. Sci. Technol. 2018, 47, 159–166.
Crossref Google Scholar
[69]

Yu, Y. B.; Feng, R. X.; Yu, S. H.; Li, J. Y.; Wang, Y. Y.; Song, Y. M.; Yang, X. G.; Pan, W. S.; Li, S. M. Nanostructured lipid carrier-based pH and temperature dual-responsive hydrogel composed of carboxymethyl chitosan and poloxamer for drug delivery. Int. J. Biol. Macromol. 2018, 114, 462–469.
Crossref Google Scholar
[70]

Mo, Z. J.; Ban, J. F.; Zhang, Y.; Du, Y. Y.; Wen, Y. F.; Huang, X.; Xie, Q. C.; Shen, L.; Zhang, S.; Deng, H. et al. Nanostructured lipid carriers-based thermosensitive eye drops for enhanced, sustained delivery of dexamethasone. Nanomedicine (Lond) 2018, 13, 1239–1253.
Crossref Google Scholar
[71]

Jabir, N. R.; Tabrez, S.; Firoz, C. K.; Zaidi, S. K.; Baeesa, S. S.; Gan, S. H.; Shakil, S.; Kamal, M. A. A synopsis of nano-technological approaches toward anti-epilepsy therapy: Present and future research implications. Curr. Drug Metab. 2015, 16, 336–345.
Crossref Google Scholar
[72]

El-Enin, H. A.; Al-Shanbari, A. H. Nanostructured liquid crystalline formulation as a remarkable new drug delivery system of anti-epileptic drugs for treating children patients. Saudi Pharm. J. 2018, 26, 790–800.
Crossref Google Scholar
[73]

Tafaghodi, M.; Tabassi, S. A. S.; Jaafari, M. R.; Zakavi, S. R.; Momen-Nejad, M. Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy. Int. J. Pharmaceut. 2004, 280, 125–135.
Crossref Google Scholar
[74]

Rabiee, N.; Ahmadi, S.; Afshari, R.; Khalaji, S.; Rabiee, M.; Bagherzadeh, M.; Fatahi, Y.; Dinarvand, R.; Tahriri, M.; Tayebi, L. et al. Polymeric nanoparticles for nasal drug delivery to the brain: Relevance to Alzheimer’s disease. Adv. Ther. 2021, 4, 2000076.
Crossref Google Scholar
[75]

Jani, P.; Vanza, J.; Pandya, N.; Tandel, H. Formulation of polymeric nanoparticles of antidepressant drug for intranasal delivery. Ther. Deliv. 2019, 10, 683–696.
Crossref Google Scholar
[76]

Tong, G. F.; Qin, N.; Sun, L. W. Development and evaluation of Desvenlafaxine loaded PLGA-chitosan nanoparticles for brain delivery. Saudi Pharm. J. 2017, 25, 844–851.
Crossref Google Scholar
[77]

Nunes, R.; Araújo, F.; Barreiros, L.; Bártolo, I.; Segundo, M. A.; Taveira, N.; Sarmento, B.; das Neves, J. Noncovalent PEG coating of nanoparticle drug carriers improves the local pharmacokinetics of rectal anti-HIV microbicides. ACS Appl. Mater. Interfaces 2018, 10, 34942–34953.
Crossref Google Scholar
[78]

Ahmad, M. Z.; Sabri, A. H. B.; Anjani, Q. K.; Dominguez-Robles, J.; Latip, N. A.; Hamid, K. A. Design and development of levodopa loaded polymeric nanoparticles for intranasal delivery. Pharmaceuticals (Basel) 2022, 15, 370.
Crossref Google Scholar
[79]

Raj, R.; Wairkar, S.; Sridhar, V.; Gaud, R. Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity. Int. J. Biol. Macromol. 2018, 109, 27–35.
Crossref Google Scholar
[80]

Shrestha, N.; Khan, S.; Neupane, Y. R.; Dang, S.; Md, S.; Fahmy, U. A.; Kotta, S.; Alhakamy, N. A.; Baboota, S.; Ali, J. Tailoring midazolam-loaded chitosan nanoparticulate formulation for enhanced brain delivery via intranasal route. Polymers (Basel) 2020, 12, 2589.
Crossref Google Scholar
[81]

Chatzitaki, A. T.; Jesus, S.; Karavasili, C.; Andreadis, D.; Fatouros, D. G.; Borges, O. Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety. Int. J. Pharm. 2020, 589, 119776.
Crossref Google Scholar
[82]

Chen, J. W.; Hu, L. D.; Yang, G.; Hu, Q. F. Current therapeutic strategy in the nasal delivery of insulin: Recent advances and future directions. Curr. Pharm. Biotechnol. 2018, 19, 400–415.
Crossref Google Scholar
[83]
Kumbhare, M.; Surana, A. R.; Morankar, P. G. Nose-to-brain delivery of insulin nanoparticles for diabetes management: A review. Baghdad J. Biochem. Appl. Biol. Sci. 2023 , 4.
Crossref
[84]

Tashima, T. Shortcut approaches to substance delivery into the brain based on intranasal administration using nanodelivery strategies for insulin. Molecules 2020, 25, 5188.
Crossref Google Scholar
[85]

Wei, X. S.; Duan, X. Z.; Zhang, Y. F.; Ma, Z.; Li, C. X.; Zhang, X. G. Internalization mechanism of phenylboronic-acid-decorated nanoplatform for enhanced nasal insulin delivery. ACS Appl. Bio Mater. 2020, 3, 2132–2139.
Crossref Google Scholar
[86]

Ban, J. F.; Zhang, Y.; Huang, X.; Deng, G. H.; Hou, D. Z.; Chen, Y. Z.; Lu, Z. F. Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone. Int. J. Nanomedicine. 2017, 12, 1329–1339.
Crossref Google Scholar
[87]

Mittal, N.; Kaur, G. Leucaena leucocephala (Lam.) galactomannan nanoparticles: Optimization and characterization for ocular delivery in glaucoma treatment. Int. J. Biol. Macromol. 2019, 139, 1252–1262.
Crossref Google Scholar
[88]

Jacinto, T. A.; Oliveira, B.; Miguel, S. P.; Ribeiro, M. P.; Coutinho, P. Ciprofloxacin-loaded zein/hyaluronic acid nanoparticles for ocular mucosa delivery. Pharmaceutics 2022, 14, 1557.
Crossref Google Scholar
[89]

Dubashynskaya, N.; Poshina, D.; Raik, S.; Urtti, A.; Skorik, Y. A. Polysaccharides in ocular drug delivery. Pharmaceutics 2019, 12, 22.
Crossref Google Scholar
[90]

Zhang, X. D.; Wei, D. Y.; Xu, Y.; Zhu, Q. Hyaluronic acid in ocular drug delivery. Carbohydr. Polym. 2021, 264, 118006.
Crossref Google Scholar
[91]

Constantinides, P. P.; Han, J. H.; Davis, S. S. Advances in the use of tocols as drug delivery vehicles. Pharm. Res. 2006, 23, 243–255.
Crossref Google Scholar
[92]

Rachmawati, H.; Pradana, A. T.; Safitri, D.; Adnyana, I. K. Multiple functions of D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) as curcumin nanoparticle stabilizer: In vivo kinetic profile and anti-ulcerative colitis analysis in animal model. Pharmaceutics 2017, 9, 24.
Crossref Google Scholar
[93]

Shah, B.; Khunt, D.; Misra, M.; Padh, H. Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route. Int. J. Biol. Macromol. 2016, 89, 206–218.
Crossref Google Scholar
[94]

Pang, L. L.; Zhu, S. Q.; Ma, J. Q.; Zhu, L.; Liu, Y. J.; Ou, G.; Li, R. T.; Wang, Y. X.; Liang, Y.; Jin, X. et al. Intranasal temperature-sensitive hydrogels of cannabidiol inclusion complex for the treatment of post-traumatic stress disorder. Acta Pharm. Sin. B. 2021, 11, 2031–2047.
Crossref Google Scholar
[95]

Bhandwalkar, M. J.; Avachat, A. M. Thermoreversible nasal in situ gel of venlafaxine hydrochloride: Formulation, characterization, and pharmacodynamic evaluation. AAPS PharmSciTech 2013, 14, 101–110.
Crossref Google Scholar
[96]

Shen, Y. B.; Hao, T. Y.; Ou, S. Y.; Hu, C. R.; Chen, L. Applications and perspectives of nanomaterials in novel vaccine development. MedChemComm 2018, 9, 226–238.
Crossref Google Scholar
[97]

Bachelder, E. M.; Beaudette, T. T.; Broaders, K. E.; Paramonov, S. E.; Dashe, J.; Frechet, J. M. J. Acid-degradable polyurethane particles for protein-based vaccines: Biological evaluation and in vitro analysis of particle degradation products. Mol. Pharm. 2008, 5, 876–884.
Crossref Google Scholar
[98]

Elmowafy, E. M.; Tiboni, M.; Soliman, M. E. Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles. J. Pharm. Invest. 2019, 49, 347–380.
Crossref Google Scholar
[99]

Lycke, N. Recent progress in mucosal vaccine development: Potential and limitations. Nat. Rev. Immunol. 2012, 12, 592–605.
Crossref Google Scholar
[100]

Kumar, M.; Dogra, R.; Mandal, U. K. Nanomaterial-based delivery of vaccine through nasal route: Opportunities, challenges, advantages, and limitations. J. Drug Deliv. Sci. Technol. 2022, 74, 103533.
Crossref Google Scholar
[101]

Alkie, T. N.; Yitbarek, A.; Taha-Abdelaziz, K.; Astill, J.; Sharif, S. Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens. PLoS One 2018, 13, e0206324.
Crossref Google Scholar
[102]

Lebre, F.; Borchard, G.; Faneca, H.; de Lima, M. C. P.; Borges, O. Intranasal administration of novel chitosan nanoparticle/DNA complexes induces antibody response to hepatitis B surface antigen in mice. Mol. Pharm. 2016, 13, 472–482.
Crossref Google Scholar
[103]

Pan, L.; Zhang, Z. W.; Lv, J. L.; Zhou, P.; Hu, W. F.; Fang, Y. Z.; Chen, H. T.; Liu, X. S.; Shao, J. J.; Zhao, F. R. et al. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles. Int. J. Nanomedicine 2014, 9, 5603–5618.
Crossref Google Scholar
[104]

Liu, Q. F.; Zheng, X. Y.; Zhang, C.; Shao, X. Y.; Zhang, X.; Zhang, Q. Z.; Jiang, X. G. Conjugating influenza a (H1N1) antigen to n-trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration. J. Med. Virol. 2015, 87, 1807–1815.
Crossref Google Scholar
[105]

Dhakal, S.; Renu, S.; Ghimire, S.; Lakshmanappa, Y. S.; Hogshead, B. T.; Feliciano-Ruiz, N.; Lu, F. J.; HogenEsch, H.; Krakowka, S.; Lee, C. W. et al. Mucosal immunity and protective efficacy of intranasal inactivated influenza vaccine is improved by chitosan nanoparticle delivery in pigs. Front. Immunol. 2018, 9, 934.
Crossref Google Scholar
[106]

Bento, D.; Staats, H. F.; Gonçalves, T.; Borges, O. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity. Eur. J. Pharm. Biopharm. 2015, 93, 149–164.
Crossref Google Scholar
[107]

Shim, S.; Soh, S. H.; Im, Y. B.; Park, H. E.; Cho, C. S.; Kim, S.; Yoo, H. S. Elicitation of Th1/Th2 related responses in mice by chitosan nanoparticles loaded with Brucella abortus malate dehydrogenase, outer membrane proteins 10 and 19. Int. J. Med. Microbiol. 2020, 310, 151362.
Crossref Google Scholar
[108]

Li, Y. M.; Wang, C.; Sun, Z. J.; Xiao, J.; Yan, X. L.; Chen, Y. Q.; Yu, J.; Wu, Y. M. Simultaneous intramuscular and intranasal administration of chitosan nanoparticles-adjuvanted Chlamydia vaccine elicits elevated protective responses in the lung. Int. J. Nanomedicine 2019, 14, 8179–8193.
Crossref Google Scholar
[109]

Khanifar, J.; Salmanian, A. H.; Hosseini, R. H.; Amani, J.; Kazemi, R. Chitosan nano-structure loaded with recombinant E. coli O157: H7 antigens as a vaccine candidate can effectively increase immunization capacity. Artif. Cells Nanomed. Biotechnol. 2019, 47, 2593–2604.
Crossref Google Scholar
[110]

Singh, J.; Pandit, S.; Bramwell, V. W.; Alpar, H. O. Diphtheria toxoid loaded poly-(ε-caprolactone) nanoparticles as mucosal vaccine delivery systems. Methods 2006, 38, 96–105.
Crossref Google Scholar
[111]

Dehghan, S.; Tafaghodi, M.; Bolourieh, T.; Mazaheri, V.; Torabi, A.; Abnous, K.; Kheiri, M. T. Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants. Int. J. Pharm. 2014, 475, 1–8.
Crossref Google Scholar
[112]

Cruz-Reséndiz, A.; Zepeda-Cervantes, J.; Sampieri, A.; Bastián-Eugenio, C.; Acero, G.; Sanchez-Betancourt, J. I.; Gevorkian, G.; Vaca, L. A self-aggregating peptide: Implications for the development of thermostable vaccine candidates. BMC Biotechnol. 2020, 20, 1.
Crossref Google Scholar
[113]

Cruz-Resendiz, A.; Acero, G.; Sampieri, A.; Gevorkian, G.; Salvador, C.; Escobar, L.; Rosendo-Pineda, M. J.; Medeiros, M.; Vaca, L. An ambient-temperature stable nanoparticle-based vaccine for nasal application that confers long-lasting immunogenicity to carried antigens. Front. Immunol. 2022, 13, 1057499.
Crossref Google Scholar
[114]

Tan, M. S. A.; Parekh, H. S.; Pandey, P.; Siskind, D. J.; Falconer, J. R. Nose-to-brain delivery of antipsychotics using nanotechnology: A review. Expert Opin. Drug Deliv. 2020, 17, 839–853.
Crossref Google Scholar
[115]

Ansari, M. A.; Chung, I. M.; Rajakumar, G.; Alzohairy, M. A.; Alomary, M. N.; Thiruvengadam, M.; Pottoo, F. H.; Ahmad, N. Current nanoparticle approaches in nose to brain drug delivery and anticancer therapy—A review. Curr. Pharm. Des. 2020, 26, 1128–1137.
Crossref Google Scholar
[116]

Wang, L. X.; Tang, S. N.; Yu, Y. W.; Lv, Y. N.; Wang, A. P.; Yan, X. J.; Li, N. N.; Sha, C. J.; Sun, K. X.; Li, Y. X. Intranasal delivery of temozolomide-conjugated gold nanoparticles functionalized with anti-EphA3 for glioblastoma targeting. Mol. Pharm. 2021, 18, 915–927.
Crossref Google Scholar
[117]
Devi, C.; Kalita, P.; Choudhury, D.; Barthakur, M. Chapter 5—Preparation and characterization of gold nanoparticles conjugated insulin. In Smart Healthcare for Disease Diagnosis and Prevention. Paul, S.; Bhatia, D., Eds.; Academic Press: London, 2020; pp 29–32.
Crossref
[118]

Joshi, H. M.; Bhumkar, D. R.; Joshi, K.; Pokharkar, V.; Sastry, M. Gold nanoparticles as carriers for efficient transmucosal insulin delivery. Langmuir 2006, 22, 300–305.
Crossref Google Scholar
[119]

Bhumkar, D. R.; Joshi, H. M.; Sastry, M.; Pokharkar, V. B. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm. Res. 2007, 24, 1415–1426.
Crossref Google Scholar
[120]

Hosseini, S.; Epple, M. Suppositories with bioactive calcium phosphate nanoparticles for intestinal transfection and gene silencing. Nano Select 2021, 2, 561–572.
Crossref Google Scholar
[121]

Kulkarni, R.; Fanse, S.; Burgess, D. J. Mucoadhesive drug delivery systems: A promising noninvasive approach to bioavailability enhancement. Part II: Formulation considerations. Expert Opin. Drug Deliv. 2023, 20, 413–434.
Crossref Google Scholar
Nano Research
Volume 17 Issue 4,
April 2024
Pages 2874-2885
DOI: 10.1007/s12274-023-6188-7
Cite this article:
Zhang L, Yang C, Song Y, et al. Advances of nanoparticles in transmucosal drug delivery. Nano Research, 2024, 17(4): 2874-2885. https://doi.org/10.1007/s12274-023-6188-7
Topics:
Drug delivery

941

Views

3

Crossref

1

Web of Science

2

Scopus

0

CSCD

Altmetrics
Received: 29 July 2023
Revised: 09 September 2023
Accepted: 11 September 2023
Published: 21 November 2023
© Tsinghua University Press 2023
Return